Activity-based CDK19/CycC kinase assay for compound screening and profiling via 33PanQinaseTM – assay technology
Target Overview
RBE Target ID
CDK19/CycC
Enzyme
Human CDK19/CycC, wt
HGNC
CDK19-CCNC
Manning ID
CDK11
Synonym
KIAA1028, bA346C16.3, CDC2L6, CDK19, CDC2L6, CDK11, CDK19/CycC, CDK19/cyclin C
UniProt
Q9BWU1 (CDK19_HUMAN)
Kinase Type
Protein kinase
Kinase Group
CMGC
Assay Properties
Assay Format
33PanQinaseTM
Substrates
RBER-IRStide, ATP
Reaction
RBER-IRStide + 33P-ATP = 33P-RBER-IRStide + ADP
Readout
Enzymatic activity
Technical Reference Compound IC50 value(s)
| Compounds | IC50 (nM) |
|---|---|
| Staurosporine | 60 |
| Sorafenib | 10000 |
| Sunitinib | 70000 |
Screening Location
Freiburg, Germany
Further Information
More information can be found on our website Kinase Assays
Service and Product Availability
Screening Opportunities
| FreeChoice | CDK19/CycC |
| 355 wt Profiler | Yes |
| 355 IC50 wt Profiler | Yes |
| Mutant Profiler Addon | No |
| Lipid Kinase Profiler Addon | No |
| IC50 Profiler | IC50 CDK Profiler |
Recombinant Protein Availability
| Active recombinant protein | Yes; ProQinaseTM – CDK19/CycC (Activity verified by 33PanQinaseTM-Assay) |
| Product Number | 1384-0390-1 |
| Web Shop | Reaction Biology Online Shop |
PDF